NICHI-IKO BUYS STERILE INJECTABLES PRODUCTION SITE IN THE US

摘要

Tokyo-based Nichi-Iko Pharmaceutical has moved to expand its US presence, acquiring an FDA-approved manufacturing site in North Carolina. After the acquisition of Sagent Pharmaceuticals got the company's foot in the door, the purchase of its first FDA-approved facility helps to solidify US foundations.